Citation: Mengzhu Hou, Guangping Liu, Chao Meng, Lili Dong, Yulian Fang, Lu Wang, Ning Wang, Chunquan Cai, Hanjie Wang. Circulation patterns and molecular characteristics of respiratory syncytial virus among hospitalized children in Tianjin, China, before and during the COVID-19 pandemic (2017-2022) .VIROLOGICA SINICA, 2024, 39(5) : 719-726.  http://dx.doi.org/10.1016/j.virs.2024.07.004

Circulation patterns and molecular characteristics of respiratory syncytial virus among hospitalized children in Tianjin, China, before and during the COVID-19 pandemic (2017-2022)

cstr: 32224.14.j.virs.2024.07.004
  • Corresponding author: Chunquan Cai, cqcns6@126.com
    Hanjie Wang, wanghj@tju.edu.cn
  • Received Date: 25 October 2023
    Accepted Date: 24 July 2024
    Available online: 26 July 2024
  • Respiratory syncytial virus (RSV) is the main pathogen that causes hospitalization for acute lower respiratory tract infections (ALRIs) in children. With the reopening of communities and schools, the resurgence of RSV in the COVID-19 post-pandemic era has become a major concern. To understand the circulation patterns and genotype variability of RSV in Tianjin before and during the COVID-19 pandemic, a total of 19,531 nasopharyngeal aspirate samples from hospitalized children in Tianjin from July 2017 to June 2022 were evaluated. Direct immunofluorescence and polymerase chain reaction (PCR) were used for screening RSV-positive samples and subtyping, respectively. Further analysis of mutations in the second hypervariable region (HVR2) of the G gene was performed through Sanger sequencing. Our results showed that 16.46% (3215/19,531) samples were RSV positive and a delayed increase in the RSV infection rates occurred in the winter season from December 2020 to February 2021, with the average RSV-positive rate of 35.77% (519/1451). The ON1, with H258Q and H266L substitutions, and the BA9, with T290I and T312I substitutions, are dominant strains that alternately circulate every 1-2 years in Tianjin, China, from July 2017 to June 2022. In addition, novel substitutions, such as N296Y, K221T, N230K, V251A in the BA9 genotype, and L226I in the ON1 genotype, emerged during the COVID-19 pandemic. Analysis of clinical characteristics indicated no significant differences between RSV-A and RSV-B groups. This study provides a theoretical basis for clinical prevention and treatment. However, further studies are needed to explore the regulatory mechanism of host immune responses to different lineages of ON1 and BA9 in the future.

  • 加载中
  • 10.1016j.virs.2024.07.004-ESM.docx
    1. Abrego, L. E., Delfraro, A., Franco, D., Castillo, J., Castillo, M., Moreno, B., Lopez-Verges, S., Pascale, J. M., Arbiza, J., 2017. Genetic variability of human respiratory syncytial virus group B in Panama reveals a novel genotype BA14. J. Med. Virol. 89, 1734-1742.

    2. Anderson, L. J., Jadhao, S. J., Paden, C. R., Tong, S., 2021. Functional features of the respiratory syncytial virus G protein. Viruses.13, 1214.

    3. Arnott, A., Vong, S., Mardy, S., Chu, S., Naughtin, M., Sovann, L., Buecher, C., Beaute, J., Rith, S., Borand, L., et al., 2011. A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype. J. Clin. Microbiol. 49, 3504-3513.

    4. Auksornkitti, V., Kamprasert, N., Thongkomplew, S., Suwannakarn, K., Theamboonlers, A., Samransamruajkij, R., Poovorawan, Y., 2014. Molecular characterization of human respiratory syncytial virus, 2010-2011: identification of genotype ON1 and a new subgroup B genotype in Thailand. Arch. Virol. 159, 499-507.

    5. Baek, Y. H., Choi, E. H., Song, M. S., Pascua, P. N., Kwon, H. I., Park, S. J., Lee, J. H., Woo, S. I., Ahn, B. H., Han, H. S., et al., 2012. Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea. Arch. Virol.157, 1039-1050.

    6. Bashir, U., Nisar, N., Mahmood, N., Alam, M. M., Sadia, H., Zaidi, S. S., 2017. Molecular detection and characterization of respiratory syncytial virus B genotypes circulating in Pakistani children. Infect. Genet. Evol. 47, 125-131.

    7. Blanc, A., Delfraro, A., Frabasile, S., Arbiza, J., 2005. Genotypes of respiratory syncytial virus group B identified in Uruguay. Arch. Virol. 150, 603-609.

    8. Canedo-Marroquin, G., Acevedo-Acevedo, O., Rey-Jurado, E., Saavedra, J. M., Lay, M. K., Bueno, S. M., Riedel, C. A., Kalergis, A. M., 2017. Modulation of host immunity by human respiratory syncytial virus virulence factors: a synergic inhibition of both innate and adaptive immunity. Front. Cell. Infect. Microbiol.7, 367.

    9. Chen, X., Zhu, Y., Wang, W., Li, C., An, S., Lu, G., Jin, R., Xu, B., Zhou, Y., Chen, A., et al., 2021. A multi-center study on molecular epidemiology of human respiratory syncytial virus from children with acute lower respiratory tract infections in the mainland of China between 2015 and 2019. Virol. Sin. 36, 1475-1483.

    10. Chiu, S. S., Cowling, B. J., Peiris, J. S. M., Chan, E. L. Y., Wong, W. H. S., Lee, K. P., 2022. Effects of nonpharmaceutical COVID-19 interventions on pediatric hospitalizations for other respiratory virus infections, Hong Kong. Emerg. Infect. Dis. 28, 62-68.

    11. Chuang, Y.-C., Lin, K.-P., Wang, L.-A., Yeh, T.-K., Liu, P.-Y., 2023. The impact of the COVID-19 pandemic on respiratory syncytial virus infection: a narrative review. Infect. Drug Resist. 16, 661-675.

    12. Collins, P. L., Melero, J. A., 2011. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res.162, 80-99.

    13. Cui, G., Zhu, R., Qian, Y., Deng, J., Zhao, L., Sun, Y., Wang, F., 2013. Genetic variation in attachment glycoprotein genes of human respiratory syncytial virus subgroups A and B in children in recent five consecutive years. PLoS One. 8, e75020.

    14. Dapat, I. C., Shobugawa, Y., Sano, Y., Saito, R., Sasaki, A., Suzuki, Y., Kumaki, A., Zaraket, H., Dapat, C., Oguma, T., et al., 2010. New genotypes within respiratory syncytial virus group B genotype BA in Niigata, Japan. J. Clin. Microbiol. 48, 3423-3427.

    15. Eshaghi, A., Duvvuri, V. R., Lai, R., Nadarajah, J. T., Li, A., Patel, S. N., Low, D. E., Gubbay, J. B., 2012. Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One. 7, e32807.

    16. Guo, Y.-j., Wang, B.-h., Li, L., Li, Y.-l., Chu, X.-l., Li, W., 2023. Epidemiological and genetic characteristics of respiratory syncytial virus infection in children from Hangzhou after the peak of COVID-19. J. Clin. Virol. 158, 105354.

    17. Jia, R., Lu, L., Su, L., Lin, Z., Gao, D., Lv, H., Xu, M., Liu, P., Cao, L., Xu, J., 2022. Resurgence of respiratory syncytial virus infection during COVID-19 pandemic among children in Shanghai, China. Front. Microbiol. 13, 938372.

    18. Li, Y., Wang, X., Blau, D. M., Caballero, M. T., Feikin, D. R., Gill, C. J., Madhi, S. A., Omer, S. B., Simoes, E. A. F., Campbell, H. et al., 2022. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 399, 2047-2064.

    19. Liu, P., Xu, M., Lu, L., Ma, A., Cao, L., Su, L., Dong, N., Jia, R., Zhu, X., Xu, J., 2022. The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: two years of the COVID-19 pandemic. J. Med. Virol. 94, 4696-4703.

    20. Maruo, Y., Ishikawa, S., Oura, K., Shiraishi, H., Sato, N., Suganuma, T., Mikawa, M., Sato, T., 2022. The impact of the coronavirus disease 2019 pandemic on pediatric hospitalization in Kitami, Japan. Pediatr. Int. 64, e14937.

    21. Matheson, J. W., Rich, F. J., Cohet, C., Grimwood, K., Huang, Q. S., Penny, D., Hendy, M. D., Kirman, J. R., 2006. Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years. J. Med. Virol. 78, 1354-1364.

    22. Mufson, M. A., Orvell, C., Rafnar, B., Norrby, E., 1985. Two distinct subtypes of human respiratory syncytial virus. J. Gen. Virol.66 (Pt 10), 2111-2124.

    23. Munoz-Escalante, J. C., Comas-Garcia, A., Bernal-Silva, S., Noyola, D. E., 2021. Respiratory syncytial virus B sequence analysis reveals a novel early genotype. Sci. Rep. 11, 3452.

    24. Peret, T. C., Hall, C. B., Schnabel, K. C., Golub, J. A., Anderson, L. J., 1998. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J. Gen. Virol.79, 2221-2229.

    25. Peret, T. C., Hall, C. B., Hammond, G. W., Piedra, P. A., Storch, G. A., Sullender, W. M., Tsou, C., Anderson, L. J., 2000. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J. Infect. Dis.181, 1891-1896.

    26. Redlberger-Fritz, M., Kundi, M., Aberle, S. W., Puchhammer-Stockl, E., 2021. Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J. Clin. Virol. 137, 104795.

    27. Reiche, J., Schweiger, B., 2009. Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007. J. Clin. Microbiol. 47, 1800-1810.

    28. Reicherz, F., Xu, R. Y., Abu-Raya, B., Majdoubi, A., Michalski, C., Golding, L., Stojic, A., Vineta, M., Granoski, M., Cieslak, Z., et al., 2022. Waning immunity against respiratory syncytial virus during the coronavirus disease 2019 pandemic. J. Infect. Dis. 226, 2064-2068.

    29. Ren, L., Xiao, Q., Zhou, L., Xia, Q., Liu, E., 2015. Molecular characterization of human respiratory syncytial virus subtype B: a novel genotype of subtype B circulating in China. J. Med. Virol. 87, 1-9.

    30. Tabatabai, J., Thielen, A., Lehners, N., Daeumer, M., Schnitzler, P., 2018. Respiratory syncytial virus A in haematological patients with prolonged shedding: premature stop codons and deletion of the genotype ON1 72-nucleotide-duplication in the attachment G gene. J. Clin. Virol. 98, 10-17.

    31. Tahamtan, A., Samadizadeh, S., Rastegar, M., Nakstad, B., Salimi, V., 2020. Respiratory syncytial virus infection: why does disease severity vary among individuals ? Expert Rev. Respir. Med. 14, 415-423.

    32. Thielen, B. K., Bye, E., Wang, X., Maroushek, S., Friedlander, H., Bistodeau, S., Christensen, J., Reisdorf, E., Shilts, M. H., Martin, K., et al., 2020. Summer outbreak of severe RSV-B disease, Minnesota, 2017 associated with emergence of a genetically distinct viral lineage. J. Infect. Dis. 222, 288-297.

    33. Trento, A., Galiano, M., Videla, C., Carballal, G., Garcia-Barreno, B., Melero, J. A., Palomo, C., 2003. Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J. Gen. Virol. 84, 3115-3120.

    34. Uhteg, K., Amadi, A., Forman, M., Mostafa, H. H., 2022. Circulation of non-SARS-CoV-2 respiratory pathogens and coinfection with SARS-CoV-2 amid the COVID-19 pandemic. Open Forum Infect. Dis. 9, ofab618.

    35. Ujiie, M., Tsuzuki, S., Nakamoto, T., Iwamoto, N., 2021. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg. Infect. Dis. 27, 2969-2970.

    36. Umar, S., Yang, R., Wang, X., Liu, Y., Ke, P., Qin, S., 2023. Molecular epidemiology and characteristics of respirator.y syncytial virus among hospitalized children in Guangzhou, China. Virol. J. 20, 272.

    37. Venter, M., Madhi, S. A., Tiemessen, C. T., Schoub, B. D., 2001. Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J. Gen. Virol. 82, 2117-2124.

    38. Zhao, X., Wang, C., Jiang, H., Zhang, H., Fang, F., Chen, M., Yuan, Z., Teng, Z., Liu, J., Zhang, X., 2022. Analysis of circulating respiratory syncytial virus A strains in Shanghai, China identified a new and increasingly prevalent lineage within the dominant ON1 genotype. Front. Microbiol. 13, 966235.

    39. Zheng, Y., Liu, L., Wang, S., Li, Z., Hou, M., Li, J., Yu, X. F., Zhang, W., Hua, S., 2017. Prevailing genotype distribution and characteristics of human respiratory syncytial virus in northeastern China. J. Med. Virol. 89, 222-233.

    40. Zhu, Y., Lu, G., Jin, R., Sun, Y., Shang, Y. X., Ai, J. H., Wang, R., Chen, X. P., Duan, Y. L., Zhang, M., et al., 2022. Analysis of respiratory syncytial virus infection in hospitalized children with acute lower respiratory tract infection in China from 2017 to 2020. Zhonghua Yu Fang Yi Xue Za Zhi. 56, 1739-1744.

    41. Zlateva, K. T., Lemey, P., Moes, E., Vandamme, A. M., Van Ranst, M., 2005. Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J. Virol. 79, 9157-9167.

  • 加载中

Figures(1)

Article Metrics

Article views(5234) PDF downloads(13) Cited by()

Related
Proportional views

    Circulation patterns and molecular characteristics of respiratory syncytial virus among hospitalized children in Tianjin, China, before and during the COVID-19 pandemic (2017-2022)

      Corresponding author: Chunquan Cai, cqcns6@126.com
      Corresponding author: Hanjie Wang, wanghj@tju.edu.cn
    • a. Tianjin Pediatric Research Institute, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, 300134, China;
    • b. Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China;
    • c. Department of Medical Laboratory, Tianjin Second People's Hospital, Tianjin, 300192, China;
    • d. Department of Respiratory, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, 300134, China;
    • e. School of Life Sciences, Tianjin University and Tianjin Engineering Center of Micro-Nano Biomaterials and Detection-Treatment Technology, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin, 300072, China

    Abstract: Respiratory syncytial virus (RSV) is the main pathogen that causes hospitalization for acute lower respiratory tract infections (ALRIs) in children. With the reopening of communities and schools, the resurgence of RSV in the COVID-19 post-pandemic era has become a major concern. To understand the circulation patterns and genotype variability of RSV in Tianjin before and during the COVID-19 pandemic, a total of 19,531 nasopharyngeal aspirate samples from hospitalized children in Tianjin from July 2017 to June 2022 were evaluated. Direct immunofluorescence and polymerase chain reaction (PCR) were used for screening RSV-positive samples and subtyping, respectively. Further analysis of mutations in the second hypervariable region (HVR2) of the G gene was performed through Sanger sequencing. Our results showed that 16.46% (3215/19,531) samples were RSV positive and a delayed increase in the RSV infection rates occurred in the winter season from December 2020 to February 2021, with the average RSV-positive rate of 35.77% (519/1451). The ON1, with H258Q and H266L substitutions, and the BA9, with T290I and T312I substitutions, are dominant strains that alternately circulate every 1-2 years in Tianjin, China, from July 2017 to June 2022. In addition, novel substitutions, such as N296Y, K221T, N230K, V251A in the BA9 genotype, and L226I in the ON1 genotype, emerged during the COVID-19 pandemic. Analysis of clinical characteristics indicated no significant differences between RSV-A and RSV-B groups. This study provides a theoretical basis for clinical prevention and treatment. However, further studies are needed to explore the regulatory mechanism of host immune responses to different lineages of ON1 and BA9 in the future.

    Figure (1)  Reference (41) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return